VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 126 filers reported holding VENTYX BIOSCIENCES INC in Q1 2024. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,322,700 | -58.0% | 3,170,000 | 0.0% | 0.04% | -55.7% |
| Q1 2024 | $17,435,000 | +613.4% | 3,170,000 | +4428.6% | 0.08% | +507.7% |
| Q3 2022 | $2,444,000 | -78.5% | 70,000 | -92.5% | 0.01% | -79.0% |
| Q2 2022 | $11,382,000 | -24.7% | 930,648 | -16.5% | 0.06% | -15.1% |
| Q1 2022 | $15,121,000 | -31.7% | 1,114,280 | 0.0% | 0.07% | -34.2% |
| Q4 2021 | $22,130,000 | – | 1,114,280 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 412,225 | $952,240 | 1.81% |
| Octagon Capital Advisors LP | 2,391,114 | $5,523,473 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 3,100,000 | $7,161,000 | 0.73% |
| Opaleye Management Inc. | 1,190,000 | $2,748,900 | 0.63% |
| Sio Capital Management, LLC | 778,924 | $1,799,314 | 0.49% |
| Parkman Healthcare Partners LLC | 1,160,022 | $2,679,651 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,012,749 | $2,339,450 | 0.32% |
| Redmile Group, LLC | 2,164,126 | $4,999,131 | 0.30% |
| WEXFORD CAPITAL LP | 449,046 | $1,037,296 | 0.26% |
| Vestal Point Capital, LP | 1,315,000 | $3,037,650 | 0.23% |